Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 16-May-24
Select bar for recommendation details.
Recommendations | 16-May-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast
The 2 analysts offering 12 month price targets for Arecor Therapeutics PLC have a median target of 442.00, with a high estimate of 481.00 and a low estimate of 403.00. The median estimate represents a 237.40% increase from the last price of 131.00.
High | 267.2% | 481.00 |
Med | 237.4% | 442.00 |
Low | 207.6% | 403.00 |
Earnings history & estimates
Average growth rate | -3.01% |
More ▼
Revenue history & estimates
Average growth rate | +98.91% |
More ▼